Veterinary Pharmacology Basics Flashcards
7 cards from real CVA practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Veterinary Pharmacology Basics flashcards as text
Which federal law requires veterinary practices to maintain records of Schedule II controlled substance usage for a minimum of 2 years?
Answer: Controlled Substances Act
The Controlled Substances Act (CSA) mandates that all registrants keep accurate records of Schedule II controlled drugs for at least 2 years.
What is the primary risk of using aminoglycoside antibiotics (e.g., gentamicin) in veterinary patients?
Answer: Nephrotoxicity and ototoxicity
Aminoglycosides accumulate in the kidneys and inner ear, causing nephrotoxicity and ototoxicity, especially with prolonged use or in dehydrated patients.
A dog is prescribed phenobarbital for seizure control. Which organ function should be monitored regularly due to long-term use?
Answer: Liver function
Phenobarbital is metabolized by the liver and can cause hepatotoxicity with chronic use, so liver enzyme levels should be monitored regularly.
Which route of administration is used when a drug must bypass the digestive system and liver to avoid first-pass metabolism?
Answer: Parenteral (IV/IM/SQ)
Parenteral routes such as IV, IM, and SQ bypass the GI tract and liver, preventing first-pass metabolism and ensuring greater bioavailability.
What is the correct action if a controlled substance is accidentally wasted or spilled in a veterinary clinic?
Answer: Document the waste with a witness signature in the controlled substance log
Accidental wastage of controlled substances must be documented in the controlled substance log with the amount wasted and co-signed by a witness.
Which drug is commonly used as a preanesthetic to reduce salivation and prevent bradycardia during surgery in dogs and cats?
Answer: Atropine
Atropine is an anticholinergic preanesthetic that reduces secretions and counteracts vagally induced bradycardia during anesthesia.
What term describes the ability of a drug to produce a harmful or toxic effect on a developing fetus?
Answer: Teratogenic
Teratogenicity refers to a drug's potential to cause structural or functional abnormalities in a developing embryo or fetus.